10-K Filing

SOTERA HEALTH CO CIK: 1822479 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0001822479-22-000014`
Period End Date	20211231
Filing Date	20220301
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	shc-20211231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 112 Income Statement 87 Cash Flow Statement 137 Stockholders Equity 29

Balance Sheet 112 line items

Line Item	Tag	Value	Unit	Period
Allowance for uncollectible accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$1.29M	USD	Point-in-time
Allowance for uncollectible accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$708.00K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$102.45M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.20B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$106.92M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.20B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.20B	shares	Point-in-time
Restricted cash short-term	`RestrictedCashCurrent`	$7.00K	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	286.04M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	285.99M	shares	Point-in-time
Restricted cash short-term	`RestrictedCashCurrent`	$7.00K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Accounts receivable, net of allowance for uncollectible accounts of $1,287 in 2021 and $708 in 2020	`AccountsReceivableNetCurrent`	$108.18M	USD	Point-in-time
Accounts receivable, net of allowance for uncollectible accounts of $1,287 in 2021 and $708 in 2020	`AccountsReceivableNetCurrent`	$91.73M	USD	Point-in-time
Inventories, net	`InventoryNet`	$54.29M	USD	Point-in-time
Inventories, net	`InventoryNet`	$34.09M	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	120.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	120.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	120.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$71.92M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$64.96M	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	2.74M	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	3.05M	shares	Point-in-time
Income taxes receivable	`IncomeTaxesReceivable`	$21.77M	USD	Point-in-time
Income taxes receivable	`IncomeTaxesReceivable`	$4.64M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$315.01M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$345.96M	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$650.80M	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$609.81M	USD	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$39.95M	USD	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$45.96M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$5.88M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$8.42M	USD	Point-in-time
Investment in unconsolidated affiliate	`EquityMethodInvestments`	$13.46M	USD	Point-in-time
Investment in unconsolidated affiliate	`EquityMethodInvestments`	$9.40M	USD	Point-in-time
Post-retirement asset	`DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent`	-	USD	Point-in-time
Post-retirement asset	`DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent`	$5.48M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$12.87M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$9.30M	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$598.84M	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$643.37M	USD	Point-in-time
Goodwill	`Goodwill`	$1.12B	USD	Point-in-time
Goodwill	`Goodwill`	$1.12B	USD	Point-in-time
Goodwill	`Goodwill`	$1.04B	USD	Point-in-time
Total assets	`Assets`	$2.76B	USD	Point-in-time
Total assets	`Assets`	$2.79B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$52.40M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$72.87M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$60.52M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$61.86M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$6.06M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$8.67M	USD	Point-in-time
Current portion of finance lease obligations	`FinanceLeaseLiabilityCurrent`	$1.17M	USD	Point-in-time
Current portion of finance lease obligations	`FinanceLeaseLiabilityCurrent`	$1.16M	USD	Point-in-time
Current portion of operating lease obligations	`OperatingLeaseLiabilityCurrent`	$9.38M	USD	Point-in-time
Current portion of operating lease obligations	`OperatingLeaseLiabilityCurrent`	$9.29M	USD	Point-in-time
Current portion of asset retirement obligations	`AssetRetirementObligationCurrent`	$619.00K	USD	Point-in-time
Current portion of asset retirement obligations	`AssetRetirementObligationCurrent`	$620.00K	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$6.70M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$10.45M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$140.60M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$161.16M	USD	Point-in-time
Long-term debt, less current portion	`LongTermDebt`	$1.82B	USD	Point-in-time
Long-term debt, less current portion	`LongTermDebt`	$1.74B	USD	Point-in-time
Finance lease obligations, less current portion	`FinanceLeaseLiabilityNoncurrent`	$34.94M	USD	Point-in-time
Finance lease obligations, less current portion	`FinanceLeaseLiabilityNoncurrent`	$40.88M	USD	Point-in-time
Operating lease obligations, less current portion	`OperatingLeaseLiabilityNoncurrent`	$33.02M	USD	Point-in-time
Operating lease obligations, less current portion	`OperatingLeaseLiabilityNoncurrent`	$38.94M	USD	Point-in-time
Noncurrent asset retirement obligations	`AssetRetirementObligationsNoncurrent`	$41.83M	USD	Point-in-time
Noncurrent asset retirement obligations	`AssetRetirementObligationsNoncurrent`	$45.01M	USD	Point-in-time
Deferred lease income	`DeferredRentCreditNoncurrent`	$21.25M	USD	Point-in-time
Deferred lease income	`DeferredRentCreditNoncurrent`	$20.75M	USD	Point-in-time
Post-retirement obligations	`PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent`	$48.22M	USD	Point-in-time
Post-retirement obligations	`PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent`	$11.46M	USD	Point-in-time
Mandatorily redeemable noncontrolling interest	`SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent`	-	USD	Point-in-time
Mandatorily redeemable noncontrolling interest	`SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent`	$13.62M	USD	Point-in-time
Noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$17.51M	USD	Point-in-time
Noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$16.27M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$134.50M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$121.82M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.31B	USD	Point-in-time
Total liabilities	`Liabilities`	$2.20B	USD	Point-in-time
See Commitments and contingencies note	`CommitmentsAndContingencies`	-	USD	Point-in-time
See Commitments and contingencies note	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, with $0.01 par value, 1,200,000 shares authorized, respectively; 286,037 and 285,990 shares issued at December 31, 2021 and 2020, respectively	`CommonStockValue`	$2.86M	USD	Point-in-time
Common stock, with $0.01 par value, 1,200,000 shares authorized, respectively; 286,037 and 285,990 shares issued at December 31, 2021 and 2020, respectively	`CommonStockValue`	$2.86M	USD	Point-in-time
Preferred stock, with $0.01 par value, 120,000 shares authorized, respectively; no shares issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, with $0.01 par value, 120,000 shares authorized, respectively; no shares issued	`PreferredStockValue`	-	USD	Point-in-time
Treasury stock, at cost (3,052 and 2,742 shares at December 31, 2021 and 2020, respectively)	`TreasuryStockValue`	$33.55M	USD	Point-in-time
Treasury stock, at cost (3,052 and 2,742 shares at December 31, 2021 and 2020, respectively)	`TreasuryStockValue`	$34.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.17B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.17B	USD	Point-in-time
Retained deficit	`RetainedEarningsAccumulatedDeficit`	$-589.13M	USD	Point-in-time
Retained deficit	`RetainedEarningsAccumulatedDeficit`	$-472.25M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-83.57M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-93.84M	USD	Point-in-time
Total equity attributable to Sotera Health Company	`StockholdersEquity`	$452.30M	USD	Point-in-time
Total equity attributable to Sotera Health Company	`StockholdersEquity`	$586.10M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$2.27M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	-	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$45.49M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$454.57M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$586.10M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-641.13M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$2.76B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$2.79B	USD	Point-in-time

Income Statement 87 line items

Line Item	Tag	Value	Unit	Period
Pension and post-retirement benefits, tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$-8.92M	USD	Annual
Pension and post-retirement benefits, tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$5.74M	USD	Annual
Pension and post-retirement benefits, tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$4.08M	USD	Annual
Interest rate swaps, tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	$-63.00K	USD	Annual
Interest rate swaps, tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	$142.00K	USD	Annual
Interest rate swaps, tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	$63.00K	USD	Annual
Total net revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$931.48M	USD	Annual
Total net revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$778.33M	USD	Annual
Total net revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$818.16M	USD	Annual
Total cost of revenues	`CostOfRevenue`	$382.90M	USD	Annual
Total cost of revenues	`CostOfRevenue`	$412.81M	USD	Annual
Total cost of revenues	`CostOfRevenue`	$374.59M	USD	Annual
Gross profit	`GrossProfit`	$443.57M	USD	Annual
Gross profit	`GrossProfit`	$518.67M	USD	Annual
Gross profit	`GrossProfit`	$395.43M	USD	Annual
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$198.16M	USD	Annual
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$178.53M	USD	Annual
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$147.48M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssetsNonproduction`	$58.56M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssetsNonproduction`	$63.78M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssetsNonproduction`	$59.03M	USD	Annual
Impairment of long-lived assets	`ImpairmentOfLongLivedAssetsHeldForUse`	$5.79M	USD	Annual
Impairment of long-lived assets	`ImpairmentOfLongLivedAssetsHeldForUse`	-	USD	Annual
Impairment of long-lived assets	`ImpairmentOfLongLivedAssetsHeldForUse`	-	USD	Annual
Total operating expenses	`OperatingExpenses`	$237.55M	USD	Annual
Total operating expenses	`OperatingExpenses`	$261.94M	USD	Annual
Total operating expenses	`OperatingExpenses`	$211.83M	USD	Annual
Operating income	`OperatingIncomeLoss`	$256.73M	USD	Annual
Operating income	`OperatingIncomeLoss`	$206.02M	USD	Annual
Operating income	`OperatingIncomeLoss`	$183.60M	USD	Annual
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-157.73M	USD	Annual
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-215.26M	USD	Annual
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-74.19M	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-20.68M	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-30.17M	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-44.26M	USD	Annual
Foreign exchange loss (gain)	`ForeignCurrencyTransactionGainLossBeforeTax`	$5.23M	USD	Annual
Foreign exchange loss (gain)	`ForeignCurrencyTransactionGainLossBeforeTax`	$-3.86M	USD	Annual
Foreign exchange loss (gain)	`ForeignCurrencyTransactionGainLossBeforeTax`	$-1.34M	USD	Annual
Other income, net	`OtherNonoperatingIncomeExpense`	$9.41M	USD	Annual
Other income, net	`OtherNonoperatingIncomeExpense`	$7.25M	USD	Annual
Other income, net	`OtherNonoperatingIncomeExpense`	$15.20M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-38.86M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-916.00K	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$175.72M	USD	Annual
Provision (benefit) for income taxes	`IncomeTaxExpenseBenefit`	$-1.37M	USD	Annual
Provision (benefit) for income taxes	`IncomeTaxExpenseBenefit`	$58.59M	USD	Annual
Provision (benefit) for income taxes	`IncomeTaxExpenseBenefit`	$19.51M	USD	Annual
Net income (loss)	`ProfitLoss`	$-20.43M	USD	Annual
Net income (loss)	`ProfitLoss`	$117.12M	USD	Annual
Net income (loss)	`ProfitLoss`	$-37.49M	USD	Annual
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$425.00K	USD	Annual
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.13M	USD	Annual
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$239.00K	USD	Annual
Net income (loss) attributable to Sotera Health Company	`NetIncomeLoss`	$116.88M	USD	Annual
Net income (loss) attributable to Sotera Health Company	`NetIncomeLoss`	$-20.85M	USD	Annual
Net income (loss) attributable to Sotera Health Company	`NetIncomeLoss`	$-38.62M	USD	Annual
Pension and post-retirement benefits (net of taxes of $8,924, $(5,737) and $(4,085), respectively)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-26.56M	USD	Annual
Pension and post-retirement benefits (net of taxes of $8,924, $(5,737) and $(4,085), respectively)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$12.13M	USD	Annual
Pension and post-retirement benefits (net of taxes of $8,924, $(5,737) and $(4,085), respectively)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$17.03M	USD	Annual
Interest rate swaps (net of taxes of $142, $(63) and $63, respectively)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$179.00K	USD	Annual
Interest rate swaps (net of taxes of $142, $(63) and $63, respectively)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-179.00K	USD	Annual
Interest rate swaps (net of taxes of $142, $(63) and $63, respectively)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$404.00K	USD	Annual
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-16.39M	USD	Annual
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$17.46M	USD	Annual
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$27.40M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$127.69M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-37.24M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-4.97M	USD	Annual
Less: comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$830.00K	USD	Annual
Less: comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$310.00K	USD	Annual
Less: comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$534.00K	USD	Annual
Comprehensive income (loss) attributable to Sotera Health Company	`ComprehensiveIncomeNetOfTax`	$-5.28M	USD	Annual
Comprehensive income (loss) attributable to Sotera Health Company	`ComprehensiveIncomeNetOfTax`	$127.16M	USD	Annual
Comprehensive income (loss) attributable to Sotera Health Company	`ComprehensiveIncomeNetOfTax`	$-38.07M	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.16	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.09	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.41	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.41	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.16	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.09	USD	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	237.70M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	279.23M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	232.40M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	279.38M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	232.40M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	237.70M	shares	Annual

Cash Flow Statement 137 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-20.43M	USD	Annual
Net income (loss)	`ProfitLoss`	$117.12M	USD	Annual
Net income (loss)	`ProfitLoss`	$-37.49M	USD	Annual
Depreciation	`Depreciation`	$64.16M	USD	Annual
Depreciation	`Depreciation`	$63.31M	USD	Annual
Depreciation	`Depreciation`	$66.67M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$80.25M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$80.05M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$86.74M	USD	Annual
Impairment of long-lived assets	`ImpairmentOfLongLivedAssetsHeldForUse`	$5.79M	USD	Annual
Impairment of long-lived assets	`ImpairmentOfLongLivedAssetsHeldForUse`	-	USD	Annual
Impairment of long-lived assets	`ImpairmentOfLongLivedAssetsHeldForUse`	-	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-20.68M	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-30.17M	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-44.26M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-3.72M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-18.99M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-23.36M	USD	Annual
Share-based non-cash compensation expense	`ShareBasedCompensation`	$13.87M	USD	Annual
Share-based non-cash compensation expense	`ShareBasedCompensation`	$6.88M	USD	Annual
Share-based non-cash compensation expense	`ShareBasedCompensation`	$10.99M	USD	Annual
Accretion expense	`AssetRetirementObligationAccretionExpense`	$2.00M	USD	Annual
Accretion expense	`AssetRetirementObligationAccretionExpense`	$2.05M	USD	Annual
Accretion expense	`AssetRetirementObligationAccretionExpense`	$2.25M	USD	Annual
Unrealized foreign exchange (gains) / losses	`ForeignCurrencyTransactionGainLossUnrealized`	$10.60M	USD	Annual
Unrealized foreign exchange (gains) / losses	`ForeignCurrencyTransactionGainLossUnrealized`	$-3.33M	USD	Annual
Unrealized foreign exchange (gains) / losses	`ForeignCurrencyTransactionGainLossUnrealized`	$-788.00K	USD	Annual
Unrealized gain on embedded derivative instruments	`EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet`	$1.20M	USD	Annual
Unrealized gain on embedded derivative instruments	`EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet`	$3.07M	USD	Annual
Unrealized gain on embedded derivative instruments	`EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet`	$1.20M	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$8.29M	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$11.62M	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$6.16M	USD	Annual
Other	`OtherNoncashIncomeExpense`	$5.54M	USD	Annual
Other	`OtherNoncashIncomeExpense`	$12.73M	USD	Annual
Other	`OtherNoncashIncomeExpense`	$5.22M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-11.76M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-1.94M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$15.51M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$20.25M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$282.00K	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$-3.78M	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-15.32M	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$7.77M	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$3.55M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-6.02M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$19.76M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-8.97M	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$1.60M	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$3.25M	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-18.41M	USD	Annual
Income taxes payable / receivable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-7.77M	USD	Annual
Income taxes payable / receivable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$10.10M	USD	Annual
Income taxes payable / receivable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-8.14M	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-369.00K	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$724.00K	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-657.00K	USD	Annual
Other long-term assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$735.00K	USD	Annual
Other long-term assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-1.82M	USD	Annual
Other long-term assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$4.38M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$120.58M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$149.04M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$281.55M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$102.16M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$57.26M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$53.51M	USD	Annual
Purchase of Iotron Industries Canada, Inc., net of cash acquired	`PaymentsToAcquireBusinessTwoNetOfCashAcquired`	-	USD	Annual
Purchase of Iotron Industries Canada, Inc., net of cash acquired	`PaymentsToAcquireBusinessTwoNetOfCashAcquired`	-	USD	Annual
Purchase of Iotron Industries Canada, Inc., net of cash acquired	`PaymentsToAcquireBusinessTwoNetOfCashAcquired`	$105.19M	USD	Annual
Purchase of BioScience Laboratories, LLC, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Purchase of BioScience Laboratories, LLC, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Purchase of BioScience Laboratories, LLC, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$13.53M	USD	Annual
Purchase of mandatorily redeemable noncontrolling interest in Nelson Laboratories Fairfield, Inc.	`PaymentsToAcquireAdditionalInterestInSubsidiaries`	$12.43M	USD	Annual
Purchase of mandatorily redeemable noncontrolling interest in Nelson Laboratories Fairfield, Inc.	`PaymentsToAcquireAdditionalInterestInSubsidiaries`	-	USD	Annual
Purchase of mandatorily redeemable noncontrolling interest in Nelson Laboratories Fairfield, Inc.	`PaymentsToAcquireAdditionalInterestInSubsidiaries`	-	USD	Annual
Purchase of Regulatory Compliance Associates Inc., net of cash acquired	`PaymentsToAcquireBusinessThreeNetOfCashAcquired`	-	USD	Annual
Purchase of Regulatory Compliance Associates Inc., net of cash acquired	`PaymentsToAcquireBusinessThreeNetOfCashAcquired`	$31.02M	USD	Annual
Purchase of Regulatory Compliance Associates Inc., net of cash acquired	`PaymentsToAcquireBusinessThreeNetOfCashAcquired`	-	USD	Annual
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$701.00K	USD	Annual
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	Annual
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-159.83M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-57.26M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-158.69M	USD	Annual
Dividends and distributions to shareholders	`PaymentsOfDividends`	$691.17M	USD	Annual
Dividends and distributions to shareholders	`PaymentsOfDividends`	-	USD	Annual
Dividends and distributions to shareholders	`PaymentsOfDividends`	-	USD	Annual
Proceeds from revolving credit facility and long-term borrowings	`ProceedsFromIssuanceOfLongTermDebt`	$150.00M	USD	Annual
Proceeds from revolving credit facility and long-term borrowings	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	Annual
Proceeds from revolving credit facility and long-term borrowings	`ProceedsFromIssuanceOfLongTermDebt`	$3.14B	USD	Annual
Proceeds from issuance of common stock, net of underwriting discounts and issuance costs	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from issuance of common stock, net of underwriting discounts and issuance costs	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from issuance of common stock, net of underwriting discounts and issuance costs	`ProceedsFromIssuanceOfCommonStock`	$1.16B	USD	Annual
Repurchase of common shares	`PaymentsForRepurchaseOfCommonStock`	-	USD	Annual
Repurchase of common shares	`PaymentsForRepurchaseOfCommonStock`	-	USD	Annual
Repurchase of common shares	`PaymentsForRepurchaseOfCommonStock`	$34.00M	USD	Annual
Purchase of noncontrolling interests in China subsidiaries	`PaymentsToMinorityShareholders`	-	USD	Annual
Purchase of noncontrolling interests in China subsidiaries	`PaymentsToMinorityShareholders`	$8.42M	USD	Annual
Purchase of noncontrolling interests in China subsidiaries	`PaymentsToMinorityShareholders`	-	USD	Annual
Payments of debt issuance costs and prepayment premium	`PaymentsOfDebtIssuanceCosts`	$17.03M	USD	Annual
Payments of debt issuance costs and prepayment premium	`PaymentsOfDebtIssuanceCosts`	$6.79M	USD	Annual
Payments of debt issuance costs and prepayment premium	`PaymentsOfDebtIssuanceCosts`	$19.75M	USD	Annual
Payments on revolving credit facility and long-term borrowings	`RepaymentsOfLongTermDebt`	$1.18B	USD	Annual
Payments on revolving credit facility and long-term borrowings	`RepaymentsOfLongTermDebt`	$100.00M	USD	Annual
Payments on revolving credit facility and long-term borrowings	`RepaymentsOfLongTermDebt`	$2.56B	USD	Annual
Shares withheld for employee taxes on equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	Annual
Shares withheld for employee taxes on equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	Annual
Shares withheld for employee taxes on equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$1.43M	USD	Annual
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-642.00K	USD	Annual
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-1.46M	USD	Annual
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-1.34M	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$73.43M	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-126.03M	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-117.29M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.11M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$485.00K	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$44.00K	USD	Annual
Net increase (decrease) in cash and cash equivalents, including restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$4.47M	USD	Annual
Net increase (decrease) in cash and cash equivalents, including restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-33.76M	USD	Annual
Net increase (decrease) in cash and cash equivalents, including restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$39.43M	USD	Annual
Cash and cash equivalents, including restricted cash, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$96.79M	USD	Point-in-time
Cash and cash equivalents, including restricted cash, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$106.92M	USD	Point-in-time
Cash and cash equivalents, including restricted cash, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$63.02M	USD	Point-in-time
Cash and cash equivalents, including restricted cash, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$102.45M	USD	Point-in-time
Cash and cash equivalents, including restricted cash, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$96.79M	USD	Point-in-time
Cash and cash equivalents, including restricted cash, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$106.92M	USD	Point-in-time
Cash and cash equivalents, including restricted cash, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$63.02M	USD	Point-in-time
Cash and cash equivalents, including restricted cash, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$102.45M	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$58.77M	USD	Annual
Cash paid during the period for interest	`InterestPaidNet`	$151.00M	USD	Annual
Cash paid during the period for interest	`InterestPaidNet`	$211.28M	USD	Annual
Cash paid during the period for income taxes, net of tax refunds received	`IncomeTaxesPaidNet`	$23.99M	USD	Annual
Cash paid during the period for income taxes, net of tax refunds received	`IncomeTaxesPaidNet`	$52.01M	USD	Annual
Cash paid during the period for income taxes, net of tax refunds received	`IncomeTaxesPaidNet`	$44.61M	USD	Annual
Equipment purchases included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$14.29M	USD	Annual
Equipment purchases included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$5.20M	USD	Annual
Equipment purchases included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$14.52M	USD	Annual

Stockholders Equity 29 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$45.49M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$454.57M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$586.10M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-641.13M	USD	Point-in-time
Dividends and distributions to shareholders	`DividendsCommonStock`	$691.17M	USD	Annual
Acquisition of noncontrolling interests	`MinorityInterestDecreaseFromRedemptions`	$2.80M	USD	1 Quarter
Acquisition of noncontrolling interests	`MinorityInterestDecreaseFromRedemptions`	$8.58M	USD	Annual
Issuance of shares	`StockIssuedDuringPeriodValueNewIssues`	$1.16B	USD	Annual
Issuance of shares	`StockIssuedDuringPeriodValueNewIssues`	$1.08M	USD	Annual
Repurchase of shares	`StockRepurchasedDuringPeriodValue`	$34.00M	USD	Annual
Share-based compensation plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$10.99M	USD	Annual
Share-based compensation plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$11.33M	USD	Annual
Share-based compensation plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$6.88M	USD	Annual
Pension and post-retirement plan adjustments, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-26.56M	USD	Annual
Pension and post-retirement plan adjustments, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$12.13M	USD	Annual
Pension and post-retirement plan adjustments, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$17.03M	USD	Annual
Foreign currency translation	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$17.46M	USD	Annual
Foreign currency translation	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-16.39M	USD	Annual
Foreign currency translation	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$27.40M	USD	Annual
Interest rate swaps	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$179.00K	USD	Annual
Interest rate swaps	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-179.00K	USD	Annual
Interest rate swaps	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$404.00K	USD	Annual
Net income (loss)	`ProfitLoss`	$-20.43M	USD	Annual
Net income (loss)	`ProfitLoss`	$117.12M	USD	Annual
Net income (loss)	`ProfitLoss`	$-37.49M	USD	Annual
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$45.49M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$454.57M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$586.10M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-641.13M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.